Prophylaxis of acute graft-versus-host disease by CCR5 blockade combined with cyclosporine A in a murine model

The importance of bone marrow involvement in GVHD

(2014) C. A. Lindemans et al.   BLOOD

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality

(2014) M. L. Sorror et al.   BLOOD

In Vitro Immunological Effects of Blocking CCR5 on T Cells

(2014) Jing Yuan et al.   INFLAMMATION

Hematopoietic stem cell transplantation activity in Europe

(2013) Alois Gratwohl et al.   CURRENT OPINION IN HEMATOLOGY

c-Rel is an essential transcription factor for the development of acute graft-versus-host disease in mice

(2013) Yu Yu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

In vitro effects of the CCR5 inhibitor maraviroc on human T cell function

(2012) H. Arberas et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Blockade of Lymphocyte Chemotaxis in Visceral Graft-versus-Host Disease

(2012) Ran Reshef et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical studies with chemokine receptor-5 (CCR5)-inhibitors

(2012) Christoph Boesecke et al.   Current Opinion in HIV and AIDS

The effect of the CCR5-delta32 deletion on global gene expression considering immune response and inflammation

(2011) Gero Hütter et al.   Journal of Inflammation-London

Chemokines and Their Receptors in Human Renal Allotransplantation

(2010) Denise J. Lo et al.   TRANSPLANTATION

Chemokine Receptor CCR5 Mediates AlloImmune Responses in Graft-versus-Host Disease

(2009) Lisa A. Palmer et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The role of chemokine receptors in acute lung allograft rejection

(2009) S. Geleff et al.   EUROPEAN RESPIRATORY JOURNAL

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

Maraviroc for Previously Treated Patients with R5 HIV-1 Infection

(2008) Roy M. Gulick et al.   NEW ENGLAND JOURNAL OF MEDICINE